Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Debt Ratio (2016 - 2023)

Historic Debt Ratio for Marker Therapeutics (MRKR) over the last 7 years, with Q1 2023 value amounting to 0.0.

  • Marker Therapeutics' Debt Ratio changed N/A to 0.0 in Q1 2023 from the same period last year, while for Mar 2023 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.07 for FY2022, which is N/A changed from last year.
  • Per Marker Therapeutics' latest filing, its Debt Ratio stood at 0.0 for Q1 2023.
  • Marker Therapeutics' 5-year Debt Ratio high stood at 0.15 for Q2 2022, and its period low was 0.0 during Q4 2019.
  • Moreover, its 3-year median value for Debt Ratio was 0.0 (2019), whereas its average is 0.04.
  • Data for Marker Therapeutics' Debt Ratio shows a peak YoY increase of 1519.33% (in 2019) and a maximum YoY decrease of 9365.49% (in 2019) over the last 5 years.
  • Quarter analysis of 3 years shows Marker Therapeutics' Debt Ratio stood at 0.0 in 2019, then soared by 10761.17% to 0.07 in 2022, then crashed by 95.2% to 0.0 in 2023.
  • Its Debt Ratio was 0.0 in Q1 2023, compared to 0.07 in Q4 2022 and 0.12 in Q3 2022.